Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Alkermes plc (ALKS) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $8.25B, a trailing price-to-earnings ratio of 22.2 and a free-cash-flow yield of 5.8%. Over the most recent reported fiscal year, revenue declined 5.2% and free cash flow per share grew 18.7%.